QUIDEL CORP /DE/ 4/A SEC Filings

Filed On	Filing
16 Sep 2020	Form 4/A: Bujarski Robert Joseph, Chief Operating Officer Granted 1,254 Restricted Stock Units · Granted 2,935 Non-Qualified Stock Options
24 Feb 2020	Form 4/A: Bryant Douglas C, Director Gave up 8,198 shares to cover exercise price or tax ($659K)
16 Sep 2019	Form 4/A: Gibson Karen, SVP, IS & Bus. Transformation Sold 4,527 shares ($306K)
22 Mar 2019	Form 4/A: Michael Edward L., Director Granted 834 Restricted Stock Units
19 May 2016	Form 4/A: Brown Thomas D, Director Received 962 shares by exercise or conversion
19 May 2016	Form 4/A: Brown Thomas D, Director Received 2,539 shares by exercise or conversion
19 May 2016	Form 4/A: Brown Thomas D, Director Received 3,499 shares by exercise or conversion
19 May 2016	Form 4/A: Brown Thomas D, Director Received 417 shares by exercise or conversion
04 Mar 2016	Form 4/A: Bujarski Robert Joseph, SVP, Bus Dev & Gen Counsel Granted 3,419 Restricted Stock Units (Converted) · Granted 1,025 Restricted Stock Units (Premium)
27 Mar 2014	Form 4/A: Pulido Mark, Director Granted 4,714 Restricted Stock Units (Converted) · Granted 1,414 Restricted Stock Units (Premium)
27 Mar 2013	Form 4/A: Tamerius John, SVP - Clinical/Reg Affairs Granted 19,736 Non-Qualified Stock Option · Granted 900 Restricted Stock Units
27 Mar 2013	Form 4/A: Steward Randall J, Chief Financial Officer Granted 39,473 Non-Qualified Stock Option · Granted 1,801 Restricted Stock Units
27 Mar 2013	Form 4/A: Stenzel Timothy Todd, Chief Science Officer Granted 24,671 Non-Qualified Stock Option · Granted 1,125 Restricted Stock Units
27 Mar 2013	Form 4/A: Smits Mark W, SVP-Commercial Operations Granted 34,539 Non-Qualified Stock Option · Granted 1,575 Restricted Stock Units
27 Mar 2013	Form 4/A: Bujarski Robert Joseph, SVP, General Counsel & Secy Granted 29,605 Non-Qualified Stock Option · Granted 1,350 Restricted Stock Units
27 Mar 2013	Form 4/A: Bryant Douglas C, Director Granted 96,217 Non-Qualified Stock Option · Granted 4,389 Restricted Stock Units
24 Jan 2013	Form 4/A: Bryant Douglas C, Director Gave up 3,681 shares to cover exercise price or tax ($78.6K)
23 Jan 2013	Form 4/A: Tamerius John, SVP - Clinical/Reg Affairs Gave up 943 shares to cover exercise price or tax ($20.1K)
23 Jan 2013	Form 4/A: Stenzel Timothy Todd, Chief Science Officer Gave up 1,022 shares to cover exercise price or tax ($21.8K)
23 Jan 2013	Form 4/A: McLeod Scot M, SVP - Operations Gave up 927 shares to cover exercise price or tax ($19.8K)

Comments